AR and prostate carcinoma: A proteomic profile study conducted on a transgenic prostate cancer mouse model exposed to methyl-selenium compounds revealed changes in proteins associated with prostate functional differentiation, androgen receptor signaling, protein folding, and endoplasmic reticulum stress responses [108].